是否SARS-CoV-2诱导IgG4合成以逃避免疫系统?
Alberto Rubio-Casillas1,2, Elrashdy M Redwan3,4, Vladimir N Uversky5,6
1Autlan Regional Hospital, Health Secretariat, Autlan 48900, Jalisco, Mexico.
Biomolecules
|September 28, 2023
概括
严重的SARS-CoV-2感染可以抑制免疫系统. 这项研究假设IgG4抗体促进免疫耐受性,通过逃避免疫监测导致持续的COVID-19.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 传染病的发病因子传染病的发病因子
背景情况:
- SARS-CoV-2 感染与免疫抑制有关,其特征是白细胞数量减少和免疫细胞功能受损.
- 严重的COVID-19可以导致细胞因子风暴和免疫细胞的直接感染,进一步损害宿主防御.
- 在SARS-CoV-2引起的免疫抑制背后的精确机制仍然不完全理解.
研究的目的:
- 研究IgG4抗体在SARS-CoV-2感染中的作用.
- 测试IgG4生产有助于免疫耐受性和持久性感染的假设.
- 探索SARS-CoV-2免疫规避和癌症免疫监测规避之间的相似之处.
主要方法:
- 分析SARS-CoV-2感染个体的免疫反应.
- 研究B细胞功能和抗体产生,特别是IgG4.
- 在病毒感染和癌症中对免疫逃避策略的比较分析.
主要成果:
- 严重的SARS-CoV-2感染与IgG4抗体的合成增加有关.
- 该研究提出,由B细胞产生的IgG4抗体诱导免疫耐受性.
- 这种耐受性机制可能会阻止病毒的消除,导致慢性感染.
结论:
- SARS-CoV-2 可能使用 IgG4 抗体生产作为一种免疫逃避策略.
- 这种机制会产生免疫耐受性,类似于癌症中观察到的免疫耐受性.
- 了解这种途径可能会揭示持续性COVID-19的新治疗点.
更多相关视频
相关概念视频
Immune Response Against Viral Pathogens
811
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
811
Humoral Immune Responses
72.9K
Overview
72.9K
Antigens Involved in Adaptive Immunity
528
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
528
Transcytosis of IgG
2.8K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.8K
Antibody Structure
60.3K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
60.3K
Cell-mediated Immune Responses
68.7K
Overview
68.7K


